Suchergebnisse - "Cao, Qian-Qian"

PubPharm (15)

1

Limited value of platelet-related markers in diagnosing periprosthetic joint infection

enthalten in: BMC musculoskeletal disorders | 2024

von Song, Z. | Huang, J. | Wang, D. | +7

2

Limited value of platelet-related markers in diagnosing periprosthetic joint infection

enthalten in: BMC musculoskeletal disorders | 2024

von Song, Z. | Huang, J. | Wang, D. | +7

3

Sulforaphane activates anti-inflammatory microglia, modulating stress resilience associated with BDNF transcription

enthalten in: Acta pharmacologica Sinica | 2022

von Tang, R. | Cao, Q. | Hu, S. | +8

4

Identification of key genes involved in axon regeneration and Wallerian degeneration by weighted gene co-expression network analysis

enthalten in: Neural regeneration research | 2022

von Lu, Y. | Shan, Q. | Ling, M. | +4

5

Transcriptome analysis of molecular mechanisms underlying facial nerve injury repair in rats

enthalten in: Neural regeneration research | 2021

von Cao, Q. | Li, S. | Lu, Y. | +4

6

Recent Advances in Asymmetric Organomulticatalysis

enthalten in: Advanced Synthesis & Catalysis | 2021

von Xiao, X. | Shao, B. | Lu, Y. | +3

7

Synthesis, structural characterization and antitumor activity of six rare earth metal complexes with 8-hydroxyquinoline derivatives

enthalten in: Journal of inorganic biochemistry | 2020

von Yang, Q. | Cao, Q. | Zhang, Y. | +7

8

Synthesis and in vitro antitumor activity evaluation of copper(II) complexes with 5-pyridin-2-yl-[1,3]dioxolo[4,5-g]isoquinoline derivatives

enthalten in: Journal of inorganic biochemistry | 2019

von Zhang, Y. | Deng, C. | Zhou, W. | +5

9

Adiponectin, exercise and eye diseases

enthalten in: International review of neurobiology | 2019

von Li, H. | Hong, X. | Cao, Q. | +1

10

Syntheses, Crystal Structures, and Antitumor Activities of Copper(II) and Nickel(II) Complexes with 2-((2-(Pyridin-2-yl)hydrazono)methyl)quinolin-8-ol

enthalten in: International journal of molecular sciences | 2018

von Yang, Q. | Cao, Q. | Qin, Q. | +3